Get the Stockscreener App
464.37
2.42%
-11.52
Overview
News
Price History
Option Chain
Financials
Why TMO Down?
Discussions
Forecast
Stock Split
Dividend History
Thermo Fisher Scientific Inc stock is traded at $464.37, with a volume of 2.97M.
It is down -2.42% in the last 24 hours and down -8.01% over the past month.
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).
See More
Previous Close:
$475.89
Open:
$478.93
24h Volume:
2.97M
Relative Volume:
1.35
Market Cap:
$172.51B
Revenue:
$44.56B
Net Income/Loss:
$6.72B
P/E Ratio:
26.18
EPS:
17.7387
Net Cash Flow:
$6.29B
1W Performance:
-7.49%
1M Performance:
-8.01%
6M Performance:
-3.15%
1Y Performance:
-8.75%
1-Day Range:
$463.81
$481.58
1-Week Range:
$463.81
$510.60
52-Week Range:
$385.46
$643.99
Thermo Fisher Scientific Inc Stock (TMO) Company Profile
Name
Thermo Fisher Scientific Inc
Sector
Industry
Phone
(781) 622-1000
Address
168 THIRD AVENUE, WALTHAM, MA
Compare TMO vs DHR, IDXX, A, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TMO
Thermo Fisher Scientific Inc
|
464.37 | 172.51B | 44.56B | 6.72B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
187.32 | 132.46B | 24.57B | 3.60B | 5.26B | 5.051 |
|
IDXX
Idexx Laboratories Inc
|
573.82 | 45.69B | 4.30B | 1.06B | 1.04B | 13.08 |
|
A
Agilent Technologies Inc
|
111.51 | 31.51B | 7.07B | 1.29B | 993.00M | 4.5355 |
|
WAT
Waters Corp
|
286.57 | 28.11B | 3.17B | 642.63M | 516.49M | 10.77 |
Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-11-25 | Upgrade | Citigroup | Neutral → Buy |
| Dec-09-25 | Initiated | Goldman | Buy |
| Dec-08-25 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Dec-02-25 | Resumed | Morgan Stanley | Overweight |
| Dec-01-25 | Upgrade | HSBC Securities | Hold → Buy |
| Sep-11-25 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-19-25 | Initiated | William Blair | Outperform |
| Jul-24-25 | Downgrade | HSBC Securities | Buy → Hold |
| Jul-11-25 | Upgrade | Scotiabank | Sector Perform → Sector Outperform |
| Jul-09-25 | Downgrade | UBS | Buy → Neutral |
| Jan-10-25 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Dec-23-24 | Initiated | Scotiabank | Sector Perform |
| Oct-14-24 | Initiated | Redburn Atlantic | Buy |
| Oct-01-24 | Initiated | Stephens | Overweight |
| Aug-28-24 | Initiated | Wells Fargo | Overweight |
| Jun-03-24 | Resumed | Jefferies | Buy |
| Mar-18-24 | Resumed | Citigroup | Neutral |
| Jan-24-24 | Downgrade | Barclays | Overweight → Equal Weight |
| Jan-08-24 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Dec-18-23 | Initiated | HSBC Securities | Buy |
| Dec-13-23 | Initiated | Wolfe Research | Outperform |
| Oct-26-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Oct-25-23 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Sep-28-23 | Initiated | Bernstein | Outperform |
| Sep-06-23 | Resumed | Citigroup | Buy |
| Jul-19-23 | Initiated | Raymond James | Outperform |
| Jul-19-23 | Reiterated | Robert W. Baird | Outperform |
| Jul-13-23 | Upgrade | Credit Suisse | Neutral → Outperform |
| Apr-04-23 | Reiterated | Barclays | Overweight |
| Dec-14-22 | Initiated | Deutsche Bank | Buy |
| Dec-07-22 | Initiated | RBC Capital Mkts | Outperform |
| Oct-27-22 | Downgrade | The Benchmark Company | Buy → Hold |
| Aug-25-22 | Initiated | Credit Suisse | Neutral |
| Apr-25-22 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| Jan-26-22 | Resumed | Barclays | Overweight |
| Oct-20-21 | Upgrade | Citigroup | Neutral → Buy |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-16-21 | Initiated | The Benchmark Company | Buy |
| Mar-18-21 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-03-21 | Initiated | Barclays | Overweight |
| Jan-08-21 | Upgrade | Credit Suisse | Neutral → Outperform |
| Dec-16-20 | Downgrade | Citigroup | Buy → Neutral |
| Dec-02-20 | Initiated | Goldman | Buy |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-30-20 | Initiated | Atlantic Equities | Overweight |
| Sep-14-20 | Initiated | Morgan Stanley | Overweight |
| Aug-20-20 | Resumed | JP Morgan | Overweight |
| Jul-15-20 | Upgrade | Cleveland Research | Neutral → Buy |
| Jul-07-20 | Reiterated | Needham | Buy |
| Apr-23-20 | Reiterated | Needham | Buy |
| Jan-31-20 | Reiterated | Needham | Buy |
| Jan-22-20 | Initiated | Credit Suisse | Neutral |
| Jan-08-20 | Initiated | Wells Fargo | Equal Weight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Nov-15-19 | Initiated | Stifel | Buy |
| Jul-25-19 | Reiterated | Needham | Buy |
| Jul-16-19 | Downgrade | Needham | Strong Buy → Buy |
| May-30-19 | Initiated | Wolfe Research | Outperform |
| May-23-19 | Reiterated | Needham | Strong Buy |
| Apr-22-19 | Reiterated | Needham | Strong Buy |
| Apr-16-19 | Reiterated | BofA/Merrill | Buy |
View All
Thermo Fisher Scientific Inc Stock (TMO) Latest News
Thermo Fisher Scientific Sees Huge Stake Increase by Broyhill Asset Management - National Today
Thermo Fisher Mikroskop: EVOS M7000 Revolution - AD HOC NEWS
Insider Sell: Michael Shafer Sells Shares of Thermo Fisher Scien - GuruFocus
Thermo Fisher Scientific Insider Sold Shares Worth $802,536, According to a Recent SEC Filing - marketscreener.com
Thermo Fisher opens new distribution centre in Ireland - Pharmafile
Mackenzie Financial Corp Acquires 62,790 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Nanobots Market Growing at 10.8% CAGR Through 2031 Driven - openPR.com
Laboratory Informatics Market Set to Witness Rapid Growth - openPR.com
EXCLUSIVE: President Donald Trump speaks 1-on-1 with Local 12 during Cincinnati visit - WKRC
President Trump makes multiple stops in Greater Cincinnati: Here's a recap - WLWT
See protests over Donald Trump's visits to Kentucky, Cincinnati - The Courier-Journal
WATCH LIVE: Trump touts economic agenda, campaigns against Rep. Massie in Kentucky - PBS
Where is Trump going in Cincinnati? What to know about the 2 locations - Cincinnati Enquirer
President Trump delivers remarks in Hebron, Ky. (LIVE) - FOX19 | Cincinnati
President Trump touts TrumpRx, pharmaceutical manufacturing push in Cincinnati visit - WCPO 9 Cincinnati
President Trump talks prescription prices, Iran war during Thermo Fisher visit - WLWT
U.S. President Donald Trump visits Thermo Fisher Scientific in Cincinnati - Reuters Connect
Trump talks prescription costs, Iran war at Thermo Fisher Scientific - Cincinnati CityBeat
President Trump visits Thermo Fisher in Reading, Ohio. See photos - WLWT
President Trump Tours Pharmaceutical Company in Cincinnati, Ohio - C-SPAN
President Trump talks drug prices, war in Iran at Thermo Fisher Scientific in Reading - FOX19 | Cincinnati
Thermo Fisher (TMO) Invests $2 Billion in U.S. Manufacturing - GuruFocus
WATCH LIVE: President Trump participates in a site visit at Thermo Fisher Scientific - WFMZ.com
WATCH LIVE: Trump visits pharmaceutical company in Cincinnati - Fox Business
A Look At Thermo Fisher Scientific (TMO) Valuation After New Cryo EM Center And Fungal Diagnostics Launch - Yahoo Finance
White House boasts $4T in new U.S. investment as Trump pushes America First - KATU
Heavy traffic expected in NKY, Cincinnati during Trump visit. What to know - The Courier-Journal
Thermo Fisher Scientific Inc. $TMO Shares Bought by Quadrant Capital Group LLC - MarketBeat
Capital International Investors Purchases 5,698 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Cell Dissociation Market Is Going to Boom |• Thermo Fisher Scientific • Merck KGaA • BD (Becton - openPR.com
Bank of Montreal Can Has $247.14 Million Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Watch President Trump tour Thermo Fisher Scientific, a pharmaceutical and biotech company - FOX19 | Cincinnati
Is Thermo Fisher Scientific (TMO) Fairly Priced After Recent Share Price Weakness? - simplywall.st
President Trump to visit Greater Cincinnati, plans to highlight local businesses - WLWT
Protest planned near Trump's stop at suburban Cincinnati manufacturer - Cincinnati Enquirer
Trump Announces Multi-State Visit Including Thermo Fisher Unit Tour - scanx.trade
[Latest] Global Pharmaceutical Microbiology QC Testing Market Size/Share Worth USD 17.65 Billion by 2035 at a 13.27% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, SWOT Analysis) - GlobeNewswire Inc.
P/E Ratio Insights for Thermo Fisher Scientific - Benzinga
Legal & General Group Plc Boosts Stake in Thermo Fisher Scientific Inc. - National Today
Van ECK Associates Corp Acquires 337,008 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Microplate Systems Market Is Going to Boom |• Thermo Fisher Scientific • Agilent Technologies - openPR.com
Commentary: Those job numbers tell us that Trump's economy really stinks - Los Angeles Times
Thermo Fisher Scientific Inc. (TMO) Announces the Opening of Cryo-Electron Microscopy Drug Discovery Center in South San Francisco - Insider Monkey
Thermo Fisher CEO Casper sells $2m in stock - Investing.com
Plant Tissue Culture Market Detailed In New Research Report 2026 - openPR.com
What to know about the businesses Trump is visiting in Cincinnati - Cincinnati Enquirer
Thermo Fisher looks to shake up Bay Area biotech with 10-foot microscope - The Business Journals
President Trump visiting Cincinnati area this week. What to know - Cincinnati Enquirer
Goldman Sachs Cuts Price Target on Thermo Fisher Scientific to $650 From $710 - marketscreener.com
WINTON GROUP Ltd Grows Stock Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific Inc. $TMO Shares Sold by LGT Fund Management Co Ltd. - MarketBeat
Thermo Fisher Scientific Inc Stock (TMO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.57%
0.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):